Home
Inbox
Search
Event
Characteristics and Outcomes of COPD Patients with Blood Eosinophils ≥150 Cells/µL Who Continue to Exacerbate Whilst Treated with Multiple Inhaler Triple Therapy [Board No. P1369]
Location:
Board no. P1369
Session Type:
Thematic Poster Session
Monday
May
21
11:15 AM
1:00 PM
Bookmark
Add to Agenda
Speaker(s)/Author(s)
Frank C. Albers
MD, PhD
GlaxoSmithKline;GSK
Dmitry Galkin
MD
GSK
Sarah Landis
Ph D
GSK
Wilhelmine H. Meeraus
PhD
GSK
Hana Müllerová
PhD, PharmDr
GSK
View Abstract
Characteristics and Outcomes of COPD Patients with Blood Eosinophils ≥150 Cells/µL Who Continue to Exacerbate Whilst Treated with Multiple Inhaler Triple Therapy
Parent Sessions
B36 - BIOMARKERS IN COPD
05-21-2018
9:15 AM - 4:15 PM
Home
Inbox
Search